COPD Trial, Recruiting NCT07027852 Sponsor: Women's College Hospital Condition: COPD
Back to Copd

COPD Trial, Recruiting

NCT07027852
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You must be able to understand and agree to take part in the study on your own (have the mental capacity to give consent)
  • You must be willing to sign and date a consent form agreeing to take part
  • You must be willing to follow all of the study's procedures and requirements
  • You must have been diagnosed with COPD (a lung condition) by a lung specialist at West China Hospital (or similar designated hospital)
  • You must be 40 years old or older
  • You must currently smoke or have smoked in the past
  • It is preferred (but not required) that you have had at least one COPD flare-up in the past 12 months that needed steroids, antibiotics, or an urgent medical visit

Who may not be able to join:

  • You have had a COPD flare-up in the 4 weeks before joining the study
  • You have also been diagnosed with asthma by a lung specialist at the study hospital
  • You have other serious health conditions that might make it difficult to take part, or you have a terminal illness (confirm with trial site)
  • You are unwilling or unable to download and use an app called "Epic Care Companion" on a suitable mobile device
  • You are currently pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Andrew Kouri, MD, Womens College Hospital

Phone: (416) 323-6400

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Women's College Hospital
Registry
ClinicalTrials.gov
Start date
15 January 2025
Est. completion
1 October 2025

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Feasibility (system use): Number of patients who started program over total offered, over one year.; Feasibility (system use): Number of patients who completed program over total started, over one year.; Feasibility (system use): Number of providers who referred patients to the program over total Number of providers, over approximately one year.; Effectiveness (clinical outcomes): Number of COPD-related outpatient visits; Effectiveness (clinical outcomes): Hospital admissions; Effectiveness (clinical outcomes): ED visits; Effectiveness (clinical outcomes): ICU admissions (at baseline will be o...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov